Lyell Immunopharma, Inc. - stock earnings
LYEL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -52.9 million USD | 13000 USD |
| 2023Q3 | -50.9 million USD | 25000 USD |
| 2023Q2 | -63.9 million USD | 27000 USD |
| 2023Q1 | -132.6 million USD | 65000 USD |
| 2022Q4 | 2.4 million USD | 48386 USD |
| 2022Q3 | -74.1 million USD | 3000 USD |
| 2022Q2 | -35.4 million USD | 35.7 million USD |
| 2022Q1 | -67.7 million USD | 553000 USD |
| 2021Q4 | -83.7 million USD | 2.8 million USD |
| 2021Q3 | -48.9 million USD | 2.8 million USD |
| 2021Q2 | -62.6 million USD | 2.6 million USD |
| 2021Q1 | -55.0 million USD | 2.4 million USD |
| 2020Q4 | -38.9 million USD | 2.3 million USD |
| 2020Q3 | -35.7 million USD | 1.1 million USD |
| 2020Q2 | -100.7 million USD | 3.1 million USD |
| 2020Q1 | -29.2 million USD | 1.3 million USD |
LYEL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -234.6 million USD | 130000 USD |
| 2022 | -4.8 million USD | 84.7 million USD |
| 2021 | -285.5 million USD | 10.7 million USD |
| 2020 | -198.5 million USD | 7.8 million USD |
| 2019 | -121.3 million USD | 657000 USD |
LYEL
Price: $2.36
52 week price:
Earnings Per Share: -0.92 USD
P/E Ratio: -2.25
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 208634
Market Capitalization: 531.1 million